The role of nitric oxide in bacterial meningitis in children

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 120-126

  Kornelisse, R F ^b   Hoekman, K ^b   Visser, J J ^b   Hop, W C J ^b   Huijmans, J G M ^b   Van Der Straaten, P J C ^b   Van Der Heijden, A J ^b   Sukhai, R N ^b   Neijens, H J ^b   De Groot, R ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; DEXAMETHASONE; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANAEROBIC GLYCOLYSIS; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 19244364936     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.120     Document Type: Article

References (10)

1. Burroughs M, Cabellos C, Prasad S, Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis 1992;165(suppl 1):S82-5.
2. Syrogiannopoulos GA, Hansen EJ, Erwin AL, et al. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis 1988;157:237-44.
3. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985;151:858-68.
4. Mustafa MM, Ramilo O, Sáez-Llorens X, Olsen KD, Magness RR, McCracken GH. Cerebrospinal fluid prostaglandins, interleukin-1β, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990;144:883-7.
5. Kadurugamuwa JL, Hengstler B, Zak O. Effects of antiinflammatory drugs on arachidonic acid metabolites and Cerebrospinal fluid proteins during infectious pneumococcal meningitis in rabbits. Pediatr Infect Dis J 1987;6:1153-4.
6. Cabellos C, Macintyre DE, Forrest M, Burroughs M, Prasad S, Tuomanen E. Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. J Clin Invest 1992;90:612-8.
7. Arditi M, Manogue KR, Caplan M, Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990;162:139-47.
8. Kadurugamuwa JL, Hengstler B, Bray MA, Zak O. Inhibition of complement factor 5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J Infect Dis 1989;160:715-9.
9. Komecki E, Ehrlich YH. Neuroregulatory and neuropathological actions of the ether phospholipid platelet-activating factor. Science 1988;240:1792-4.
10. Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A. Transforming growth factor-β2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor-α-independent early phase of experimental pneumococcal meningitis. J Exp Med 1992;176:265-8.